Boubacar Traore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Boubacar Traore has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Aissata Ongoiba
Mali International Center of Excellence in Research, University of Sciences, Technique and Technology of Bamako, Bamako, Mali
4 shared publications - Peter D. Crompton
Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health
4 shared publications - Jeff Skinner
Malaria Infection Biology and Immunity Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA
3 shared publications - Safiatou Doumbo
Mali International Center of Excellence in Research, University of Sciences, Technique and Technology of Bamako, Bamako, Mali
3 shared publications - Didier Doumtabe
Mali International Center of Excellence in Research, University of Sciences, Technique and Technology of Bamako, BP 1805, Point G, Bamako, Mali
2 shared publications - Gunjan Arora
Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States
2 shared publications
Latest Publications
- Open Access
- 17 December 2023
- Published by BMJ in BMJ Global Health
- Vol. 8 (Suppl 10) , A106.3-A107
PA-666 Adapting a COVID-19 ELISA for dried blood spot testing in Mali, West Africa
Background Serosurveillance is an important method to help monitor COVID-19 in the community in Mali. We previously adapted and qualified a two-antigen Enzyme-Linked Immunosorbent Assays for use in local laboratories using venous blood samples (95% CI, 73.9% (51.6–89.8) and 99.4% (97.7–99.9)) respectively as sensitivity and specificity). However, the burden of blood collection set cost can be challenging in resource limited region where alternative source of biological material will facilitate a large scale of COVID19 surveillance. In this study (funded by NIH) we assessed the of dried blood spot (DBS) samples to quantify Sars-Cov-2 antibodies by ELISA using RBD and Spike antigens. Methods Respectively 248, 226 and 391 volunteers were randomly selected from Sotuba (urban), Bancoumana (town) and Doneguebougou (village). Venous blood and DBS samples were collected, tested in parallel to assess concordance and the performances of the DBS samples. During the optimization phase (n=36), a promising concordance was found. This allowed us to analyze 829 additional samples on the Spike antigen. Results We had (31/36) of samples that were COVID-19 seropositive (two category kappa 1.0) in both type of samples, suggesting a strong concordance. Analysis of the 829 samples showed a high correlation (Pearson r = 0.9239 p < 0.0001) with 98% concordance between venous blood ELISA and simplified DBS spike ELISA (kappa = 0.92). As performances, the DBS showed a sensitivity of 99% (95% CI, 98%-99%) and a specificity of 99% (95% CI, 93%-100%). It had 100% (95% CI, 99%-100%) as positive predictive value, 88% (95% CI, 79%-94%) as negative predictive value. Conclusion Overall, DBS elution and testing was comparable to venous blood testing in the Malian population, and this supports it use in large-scale SARS-CoV-2 serosurveillance studies as a valuable alternative to venipuncture. Our perspective is to optimize/adapt DBS serology to other viruses like Zika virus, Ebola virus, Dengue virus, hepatitis viruses.
- 17 December 2023
- Published by BMJ in BMJ Global Health
- Vol. 8 (Suppl 10) , A106.3-A107
Open AccessPA-666 Adapting a COVID-19 ELISA for dried blood spot testing in Mali, West Africa
Background Serosurveillance is an important method to help monitor COVID-19 in the community in Mali. We previously adapted and qualified a two-antigen Enzyme-Linked Immunosorbent Assays for use in local laboratories using venous blood samples (95% CI, 73.9% (51.6–89.8) and 99.4% (97.7–99.9)) respectively as sensitivity and specificity). However, the burden of blood collection set cost can be challenging in resource limited region where alternative source of biological material will facilitate a large scale of COVID19 surveillance. In this study (funded by NIH) we assessed the of dried blood spot (DBS) samples to quantify Sars-Cov-2 antibodies by ELISA using RBD and Spike antigens. Methods Respectively 248, 226 and 391 volunteers were randomly selected from Sotuba (urban), Bancoumana (town) and Doneguebougou (village). Venous blood and DBS samples were collected, tested in parallel to assess concordance and the performances of the DBS samples. During the optimization phase (n=36), a promising concordance was found. This allowed us to analyze 829 additional samples on the Spike antigen. Results We had (31/36) of samples that were COVID-19 seropositive (two category kappa 1.0) in both type of samples, suggesting a strong concordance. Analysis of the 829 samples showed a high correlation (Pearson r = 0.9239 p < 0.0001) with 98% concordance between venous blood ELISA and simplified DBS spike ELISA (kappa = 0.92). As performances, the DBS showed a sensitivity of 99% (95% CI, 98%-99%) and a specificity of 99% (95% CI, 93%-100%). It had 100% (95% CI, 99%-100%) as positive predictive value, 88% (95% CI, 79%-94%) as negative predictive value. Conclusion Overall, DBS elution and testing was comparable to venous blood testing in the Malian population, and this supports it use in large-scale SARS-CoV-2 serosurveillance studies as a valuable alternative to venipuncture. Our perspective is to optimize/adapt DBS serology to other viruses like Zika virus, Ebola virus, Dengue virus, hepatitis viruses.
- Open Access
- 6 April 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (4) , e1009430
Plasmodium falciparum malaria drives epigenetic reprogramming of human monocytes toward a regulatory phenotype
In malaria-naïve children and adults, Plasmodium falciparum-infected red blood cells (Pf-iRBCs) trigger fever and other symptoms of systemic inflammation. However, in endemic areas where individuals experience repeated Pf infections over many years, the risk of Pf-iRBC-triggered inflammatory symptoms decreases with cumulative Pf exposure. The molecular mechanisms underlying these clinical observations remain unclear. Age-stratified analyses of uninfected, asymptomatic Malian individuals before the malaria season revealed that monocytes of adults produced lower levels of inflammatory cytokines (IL-1β, IL-6 and TNF) in response to Pf-iRBC stimulation compared to monocytes of Malian children and malaria-naïve U.S. adults. Moreover, monocytes of Malian children produced lower levels of IL-1β and IL-6 following Pf-iRBC stimulation compared to 4–6-month-old infants. Accordingly, monocytes of Malian adults produced more IL-10 and expressed higher levels of the regulatory molecules CD163, CD206, Arginase-1 and TGM2. These observations were recapitulated in an in vitro system of monocyte to macrophage differentiation wherein macrophages re-exposed to Pf-iRBCs exhibited attenuated inflammatory cytokine responses and a corresponding decrease in the epigenetic marker of active gene transcription, H3K4me3, at inflammatory cytokine gene loci. Together these data indicate that Pf induces epigenetic reprogramming of monocytes/macrophages toward a regulatory phenotype that attenuates inflammatory responses during subsequent Pf exposure. Trial Registration: ClinicalTrials.gov NCT01322581.
- 6 April 2021
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (4) , e1009430
Open AccessPlasmodium falciparum malaria drives epigenetic reprogramming of human monocytes toward a regulatory phenotype
In malaria-naïve children and adults, Plasmodium falciparum-infected red blood cells (Pf-iRBCs) trigger fever and other symptoms of systemic inflammation. However, in endemic areas where individuals experience repeated Pf infections over many years, the risk of Pf-iRBC-triggered inflammatory symptoms decreases with cumulative Pf exposure. The molecular mechanisms underlying these clinical observations remain unclear. Age-stratified analyses of uninfected, asymptomatic Malian individuals before the malaria season revealed that monocytes of adults produced lower levels of inflammatory cytokines (IL-1β, IL-6 and TNF) in response to Pf-iRBC stimulation compared to monocytes of Malian children and malaria-naïve U.S. adults. Moreover, monocytes of Malian children produced lower levels of IL-1β and IL-6 following Pf-iRBC stimulation compared to 4–6-month-old infants. Accordingly, monocytes of Malian adults produced more IL-10 and expressed higher levels of the regulatory molecules CD163, CD206, Arginase-1 and TGM2. These observations were recapitulated in an in vitro system of monocyte to macrophage differentiation wherein macrophages re-exposed to Pf-iRBCs exhibited attenuated inflammatory cytokine responses and a corresponding decrease in the epigenetic marker of active gene transcription, H3K4me3, at inflammatory cytokine gene loci. Together these data indicate that Pf induces epigenetic reprogramming of monocytes/macrophages toward a regulatory phenotype that attenuates inflammatory responses during subsequent Pf exposure. Trial Registration: ClinicalTrials.gov NCT01322581.
- Open Access
- 4 March 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (4)
Plasmodium falciparum–specific IgM B cells dominate in children, expand with malaria, and produce functional IgM
IgG antibodies play a role in malaria immunity, but whether and how IgM protects from malaria and the biology of Plasmodium falciparum (Pf)–specific IgM B cells is unclear. In a Mali cohort spanning infants to adults, we conducted longitudinal analyses of Pf- and influenza-specific B cells. We found that Pf-specific memory B cells (MBCs) are disproportionally IgM+ and only gradually shift to IgG+ with age, in contrast to influenza-specific MBCs that are predominantly IgG+ from infancy to adulthood. B cell receptor analysis showed Pf-specific IgM MBCs are somatically hypermutated at levels comparable to influenza-specific IgG B cells. During acute malaria, Pf-specific IgM B cells expand and upregulate activation/costimulatory markers. Finally, plasma IgM was comparable to IgG in inhibiting Pf growth and enhancing phagocytosis of Pf by monocytes in vitro. Thus, somatically hypermutated Pf-specific IgM MBCs dominate in children, expand and activate during malaria, and produce IgM that inhibits Pf through neutralization and opsonic phagocytosis.
- 4 March 2021
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 218 (4)
Open AccessPlasmodium falciparum–specific IgM B cells dominate in children, expand with malaria, and produce functional IgM
IgG antibodies play a role in malaria immunity, but whether and how IgM protects from malaria and the biology of Plasmodium falciparum (Pf)–specific IgM B cells is unclear. In a Mali cohort spanning infants to adults, we conducted longitudinal analyses of Pf- and influenza-specific B cells. We found that Pf-specific memory B cells (MBCs) are disproportionally IgM+ and only gradually shift to IgG+ with age, in contrast to influenza-specific MBCs that are predominantly IgG+ from infancy to adulthood. B cell receptor analysis showed Pf-specific IgM MBCs are somatically hypermutated at levels comparable to influenza-specific IgG B cells. During acute malaria, Pf-specific IgM B cells expand and upregulate activation/costimulatory markers. Finally, plasma IgM was comparable to IgG in inhibiting Pf growth and enhancing phagocytosis of Pf by monocytes in vitro. Thus, somatically hypermutated Pf-specific IgM MBCs dominate in children, expand and activate during malaria, and produce IgM that inhibits Pf through neutralization and opsonic phagocytosis.
- Open Access
- 1 May 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (1_Suppleme) , 67.7
Repeated febrile malaria exposure remodels monocytes/macrophages toward a regulatory/tolerogenic phenotype
In malaria-naïve individuals, P. falciparum (Pf) infection results in numerous Pf-infected red blood cells (iRBCs) that trigger systemic inflammation and fever. Conversely, repeatedly infected individuals in endemic areas are often asymptomatic and have low levels of iRBCs, even children who have yet to acquire reliably protective antibodies. The molecular mechanisms underlying these clinical observations are unclear. PBMCs collected from Malian children before the malaria season responded to iRBCs by producing pyrogenic, pro-inflammatory mediators such as IL-1β, IL-6 and TNF. However, following febrile malaria there was a marked shift in the response to iRBCs with the same children’s PBMCs producing lower levels of those cytokines. These data suggest that malaria-induced epigenetic reprogramming of innate immune cells may play a role in immunity to malaria. Accordingly, age-stratified analysis of monocytes collected before the malaria season showed an inverse relationship between age and pro-inflammatory cytokine production capacity. Monocytes of Malian adults expressed higher levels of CD163, CD206, Arginase-1, TGM2, molecules which are known to be associated with regulatory phenotype. These observations were recapitulated with an in vitro system of monocyte-macrophage differentiation whereby re-exposure to iRBCs was associated with diminished expression of pro-inflammatory mediators and a corresponding decrease in epigenetic markers of active gene transcription (i.e. H3K4me3) at the TSS of the same pro-inflammatory mediators. Together these data support the hypothesis that epigenetic reprogramming of monocytes/macrophages toward a regulatory phenotype contributes to clinical immunity to malaria.
- 1 May 2020
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (1_Suppleme) , 67.7
Open AccessRepeated febrile malaria exposure remodels monocytes/macrophages toward a regulatory/tolerogenic phenotype
In malaria-naïve individuals, P. falciparum (Pf) infection results in numerous Pf-infected red blood cells (iRBCs) that trigger systemic inflammation and fever. Conversely, repeatedly infected individuals in endemic areas are often asymptomatic and have low levels of iRBCs, even children who have yet to acquire reliably protective antibodies. The molecular mechanisms underlying these clinical observations are unclear. PBMCs collected from Malian children before the malaria season responded to iRBCs by producing pyrogenic, pro-inflammatory mediators such as IL-1β, IL-6 and TNF. However, following febrile malaria there was a marked shift in the response to iRBCs with the same children’s PBMCs producing lower levels of those cytokines. These data suggest that malaria-induced epigenetic reprogramming of innate immune cells may play a role in immunity to malaria. Accordingly, age-stratified analysis of monocytes collected before the malaria season showed an inverse relationship between age and pro-inflammatory cytokine production capacity. Monocytes of Malian adults expressed higher levels of CD163, CD206, Arginase-1, TGM2, molecules which are known to be associated with regulatory phenotype. These observations were recapitulated with an in vitro system of monocyte-macrophage differentiation whereby re-exposure to iRBCs was associated with diminished expression of pro-inflammatory mediators and a corresponding decrease in epigenetic markers of active gene transcription (i.e. H3K4me3) at the TSS of the same pro-inflammatory mediators. Together these data support the hypothesis that epigenetic reprogramming of monocytes/macrophages toward a regulatory phenotype contributes to clinical immunity to malaria.
- Open Access
- 1 November 2015
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 83 (11) , 4229-4236
Plasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure
Malaria elimination efforts would benefit from vaccines that block transmission ofPlasmodium falciparumgametocytes from humans to mosquitoes. A clear understanding of gametocyte-specific antibody responses in exposed populations could help determine whether transmission-blocking vaccines (TBV) would be boosted by natural gametocyte exposure, and also inform the development of serologic tools to monitor gametocyte exposure in populations targeted for malaria elimination. To this end, plasma was collected from Malian children and adults before and after the 6-month malaria season and probed against a microarray containing 1,204P. falciparumproteins. Using publicly available proteomic data, we classified 91 proteins as gametocyte specific and 69 as proteins not expressed by gametocytes. The overall breadth and magnitude of gametocyte-specific IgG responses increased during the malaria season, although they were consistently lower than IgG responses to nongametocyte antigens. Notably, IgG specific for the TBV candidates Pfs48/45 and Pfs230 increased during the malaria season. In addition, IgGs specific for the gametocyte proteins Pfmdv1, Pfs16, PF3D7_1346400, and PF3D7_1024800 were detected in nearly all subjects, suggesting that seroconversion to these proteins may be a sensitive indicator of gametocyte exposure, although further studies are needed to determine the specificity and kinetics of these potential serologic markers. These findings suggest that TBV-induced immunity would be boosted through natural gametocyte exposure, and that antibody responses to particular antigens may reliably indicate gametocyte exposure.
- 1 November 2015
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 83 (11) , 4229-4236
Open AccessPlasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure
Malaria elimination efforts would benefit from vaccines that block transmission ofPlasmodium falciparumgametocytes from humans to mosquitoes. A clear understanding of gametocyte-specific antibody responses in exposed populations could help determine whether transmission-blocking vaccines (TBV) would be boosted by natural gametocyte exposure, and also inform the development of serologic tools to monitor gametocyte exposure in populations targeted for malaria elimination. To this end, plasma was collected from Malian children and adults before and after the 6-month malaria season and probed against a microarray containing 1,204P. falciparumproteins. Using publicly available proteomic data, we classified 91 proteins as gametocyte specific and 69 as proteins not expressed by gametocytes. The overall breadth and magnitude of gametocyte-specific IgG responses increased during the malaria season, although they were consistently lower than IgG responses to nongametocyte antigens. Notably, IgG specific for the TBV candidates Pfs48/45 and Pfs230 increased during the malaria season. In addition, IgGs specific for the gametocyte proteins Pfmdv1, Pfs16, PF3D7_1346400, and PF3D7_1024800 were detected in nearly all subjects, suggesting that seroconversion to these proteins may be a sensitive indicator of gametocyte exposure, although further studies are needed to determine the specificity and kinetics of these potential serologic markers. These findings suggest that TBV-induced immunity would be boosted through natural gametocyte exposure, and that antibody responses to particular antigens may reliably indicate gametocyte exposure.